Filing Details
- Accession Number:
- 0001127602-18-003917
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-05 14:01:32
- Reporting Period:
- 2018-02-01
- Accepted Time:
- 2018-02-05 14:01:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1238337 | A Luke Pomilio | C/O Conmed Corp 525 French Road Utica NY 13502-5994 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-02-01 | 18,023 | $63.38 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-02-01 | 18,400 | $51.30 | 18,400 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-01 | 16,438 | $63.35 | 1,962 | No | 4 | F | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Sars (Stock Appreciation Rights) | Disposition | 2018-02-01 | 18,400 | $0.00 | 18,400 | $51.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 27,600 | 2025-02-27 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
- The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.
Billionaire Hedge Funds
